Skip navigation

Aurobindo Pharma USA, Inc

Public Pharmaceutical Headquartered in East Windsor, NJ 4 Active Jobs

Aurobindo Pharma USA, Inc. (Aurobindo) is a generic solid dosage, small
molecule manufacturer, and a wholly owned subsidiary of Aurobindo Pharma
Limited. Aurobindo received their first pharmaceutical approval from the United
States Food and Drug Administration in 2004. Although not among the original
U.S. generic manufacturers, Aurobindo caught up quickly. By 2014, they became
one of the top ten amongst all U.S. based generic pharmaceutical companies in
terms of total scripts dispensed. Today, they occupy 8th place.*

Heading in a positive direction and taking advantage of momentum because of a
multitude of ANDA approvals, Aurobindo invested resources in their people,
facilities, and portfolio. The investment is paying off. For example,
Aurobindo’s portfolio is now recognized as one of the most extensive in the
generic industry. As of March 2016, Aurobindo boasts a portfolio of 155 product
families with approximately 400 individual product packages.

Another characteristic of the product line is the multitude of therapeutic
categories. Formulating products for many of these categories, including
cardiovascular, anti-virals, cephalosporins, and pain management, to name the
most prominent, requires both human expertise and scientific platforms.

Aurobindo operates three US facilities comprising over 300,000 sq. ft. of
laboratory, manufacturing, packaging, warehousing, distribution, and
administrative offices with more than 425 talented associates. Today’s highly
effective and efficient processes combined with its commercial expertise has
helped Aurobindo grow exponentially within the U.S. generic market.

Despite this uncommon degree of company success, senior leadership is not
content to rest on their laurels. They continue to: challenge the status quo,
ask ‘What if’ questions, and promote a mindset that appreciates different points
of view. This reflects Aurobindo’s quest to be a stronger, more knowledge driven
company today than yesterday. It not only promotes innovation, but also fosters
an environment that is both engaging and energizing.

The commercial operation is made up of dedicated professionals in the areas
of sales, contract management, supply chain, warehousing, distribution, and
finance. This team of professionals has the look of success, yet a work ethic
reflecting a tireless commitment to getting it right. With the recent purchase
of 90 acres of land, Aurobindo plans to add 565,000 square feet to its already
impressive U.S. operation.

Aurobindo prides itself on strong scientific principles, unmatched regulatory
expertise, and a strong set of core values enabling the company to achieve
extraordinary results. From discovery to formulation to manufacturing to
commercialization, there is an atmosphere promoting collaboration, individual
and team triumphs, and a focus on ‘getting it right.’

* Source: IMS National Prescription Audit


  • Value Proposition emphasizes Quality, Value, and Breadth of line
  • Truly vertically integrated . . . assures an unbroken circle from start to finish
  • Manufacturing capabilities -- Batch sizes scaled up to meet ever increasing demand
  • Highest number of ANDA approvals from April 2015 through March 2016*
  • Sales team builds relationships with multiple stakeholders . . . from purchasing through the executive suite
  • Among the largest portfolios in the industry including 155 product families
  • Sales team focused on developing mutually beneficial solutions for their customers
  • Primed for future growth; building a 565,000 square foot facility in central New Jersey
  • Customer-centric mind set
  • Among the fastest growing pharmaceutical companies; ranked 8th in TRx's*
  • Scientific expertise; research will most likely yield more complex generics

* Source:  IMS National Prescription Audit